1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Immunofluorescent staining of cancer spheroids and fine-needle aspiration-derived organoids

      research-article

      Read this article at

      ScienceOpenPublisherPMC
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Summary

          Our organoid generation technique has allowed for the development of downstream organoid applications. Here, we detail an accessible, straightforward protocol for immunofluorescent staining and imaging of thyroid cancer organoids, particularly those with tumor de-differentiation. Immunofluorescence is a powerful tool to help understand the localization of cell types within organoids and determine the interactions between those cells. As organoids have been shown to recapitulate patient tumor morphology, immunofluorescent staining and imaging of organoids allows for enhanced understanding of near in vivo structures.

          For complete details on the use and execution of this protocol, please refer to Lee et al. (2020) and Vilgelm et al. (2020).

          Graphical Abstract

          Highlights

          • Protocol for fixation and permeabilization of intact spheroids and organoids

          • Immunofluorescent staining of both spheroids and organoids

          • Identify fibroblasts and cancer cells in 3D cultures from de-differentiated tumors

          Abstract

          Our organoid generation technique has allowed for the development of downstream organoid applications. Here, we detail an accessible, straightforward protocol for immunofluorescent staining and imaging of thyroid cancer organoids, particularly those with tumor de-differentiation. Immunofluorescence is a powerful tool to help understand the localization of cell types within organoids and determine the interactions between those cells. As organoids have been shown to recapitulate patient tumor morphology, immunofluorescent staining and imaging of organoids allows for enhanced understanding of near in vivo structures.

          Related collections

          Most cited references7

          • Record: found
          • Abstract: found
          • Article: found
          Is Open Access

          Primary Patient-Derived Cancer Cells and Their Potential for Personalized Cancer Patient Care

          Summary Personalized cancer therapy is based on a patient’s tumor lineage, histopathology, expression analyses, and/or tumor DNA or RNA analysis. Here, we aim to develop an in vitro functional assay of a patient’s living cancer cells that could complement these approaches. We present methods for developing cell cultures from tumor biopsies and identify the types of samples and culture conditions associated with higher efficiency of model establishment. Toward the application of patient-derived cell cultures for personalized care, we established an immunofluorescence-based functional assay that quantifies cancer cell responses to targeted therapy in mixed cell cultures. Assaying patient-derived lung cancer cultures with this method showed promise in modeling patient response for diagnostic use. This platform should allow for the development of co-clinical trial studies to prospectively test the value of drug profiling on tumor-biopsy-derived cultures to direct patient care.
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Fine-Needle Aspiration-Based Patient-Derived Cancer Organoids

            Summary Patient-derived cancer organoids hold great potential to accurately model and predict therapeutic responses. Efficient organoid isolation methods that minimize post-collection manipulation of tissues would improve adaptability, accuracy, and applicability to both experimental and real-time clinical settings. Here we present a simple and minimally invasive fine-needle aspiration (FNA)-based organoid culture technique using a variety of tumor types including gastrointestinal, thyroid, melanoma, and kidney. This method isolates organoids directly from patients at the bedside or from resected tissues, requiring minimal tissue processing while preserving the histologic growth patterns and infiltrating immune cells. Finally, we illustrate diverse downstream applications of this technique including in vitro high-throughput chemotherapeutic screens, in situ immune cell characterization, and in vivo patient-derived xenografts. Thus, routine clinical FNA-based collection techniques represent an unappreciated substantial source of material that can be exploited to generate tumor organoids from a variety of tumor types for both discovery and clinical applications.
              • Record: found
              • Abstract: found
              • Article: not found

              Broad-spectrum immunohistochemical epithelial markers: a review

              A relatively large number of broad-spectrum immunohistochemical epithelial markers that can be used as part of the screening panels employed in the recognition of the main cell lineages during the initial evaluation of a poorly differentiated tumor are currently available. Variations exist in the sensitivity and specificity of the individual markers that have traditionally been used for the demonstration of epithelial differentiation and in the pitfalls associated with these markers. This article reviews not only the reactivity of the various pan-keratin antibodies that are often used to assist in the demonstration of epithelial differentiation, but also that of those that have recently become available. A review of the non-keratin, broad-spectrum epithelial markers that have been recognized as being useful is also presented.

                Author and article information

                Contributors
                Journal
                STAR Protoc
                STAR Protoc
                STAR Protocols
                Elsevier
                2666-1667
                31 May 2021
                18 June 2021
                31 May 2021
                : 2
                : 2
                : 100578
                Affiliations
                [1 ]Department of Pharmacology, Vanderbilt University, Nashville, TN 37232, USA
                [2 ]Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN 37232, USA
                [3 ]Department of Cell and Developmental Biology, Vanderbilt University, Nashville, TN 37232, USA
                [4 ]Vanderbilt Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN 37232, USA
                [5 ]Department of Pathology, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL 33136, USA
                Author notes
                []Corresponding author v Vivian.l.weiss@ 123456vumc.org
                [6]

                These authors contributed equally

                [7]

                Technical contact

                [8]

                Lead contact

                Article
                S2666-1667(21)00285-9 100578
                10.1016/j.xpro.2021.100578
                8182106
                34136836
                929bd36e-6048-4f33-92ed-de511d1e64ee
                © 2021 The Authors

                This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

                History
                Categories
                Protocol

                cell culture,cancer,microscopy,organoids
                cell culture, cancer, microscopy, organoids

                Comments

                Comment on this article

                Related Documents Log